avapro has been researched along with Aortic Diseases in 5 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S | 1 |
| Wang, K | 1 |
| Xu, G | 1 |
| Ji, J | 1 |
| Qin, C | 1 |
| Li, L | 1 |
| Li, J | 1 |
| Yi, J | 1 |
| Liu, H | 1 |
| Lei, H | 1 |
| Candido, R | 1 |
| Allen, TJ | 1 |
| Lassila, M | 1 |
| Cao, Z | 1 |
| Thallas, V | 1 |
| Cooper, ME | 1 |
| Jandeleit-Dahm, KA | 1 |
| Wassmann, S | 1 |
| Czech, T | 1 |
| van Eickels, M | 1 |
| Fleming, I | 1 |
| Böhm, M | 1 |
| Nickenig, G | 1 |
| Hope, S | 1 |
| Brecher, P | 1 |
| Chobanian, AV | 1 |
5 other studies available for avapro and Aortic Diseases
| Article | Year |
|---|---|
The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Aor | 2016 |
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atheroscle | 2018 |
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseas | 2004 |
Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Arterioscleros | 2004 |
Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 1999 |